NeoImmuneTech, Inc. (950220.KQ)
KRW 1126.0
(-3.6%)
KRW 1126.0
(-3.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -49.76 Billion | -42.4 Billion | -33.88 Billion | -28.9 Billion | -14.78 Million |
| Net Income | -52.74 Billion | -59.25 Billion | -54.36 Billion | -28.08 Billion | -14.19 Million |
| Depreciation & Amortization | 3.2 Billion | 2.8 Billion | 1.87 Billion | 987.97 Million | 780.78 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 5.89 Billion | 5.63 Billion | 9.2 Billion | 3.04 Billion | - |
| Change in working capital | -3.54 Billion | 6.64 Billion | 7.68 Billion | -3.85 Billion | -627.93 Thousand |
| Other non-cash items | -2.61 Billion | -891.39 Million | 1.23 Billion | -707.25 Million | -742.98 Thousand |
| Investing Cash Flow | 2.08 Billion | -3.15 Billion | -3.82 Billion | 4.16 Billion | -4.16 Million |
| Investments in PPE | -791.38 Million | -2.47 Billion | -2.7 Billion | -1.08 Billion | -433.14 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | -21.89 Billion | -5.78 Billion |
| Sales/Maturities of investments | - | - | - | 27.57 Billion | - |
| Other Investing Activities | 39.73 Million | -125.49 Million | -1.41 Billion | -1.29 Billion | -3.73 Million |
| Financing Cash Flow | -1.13 Billion | -633.32 Million | 115.04 Billion | -31.02 Million | 72.55 Million |
| Debt repayment | -1.17 Million | -1.03 Million | -713.73 Thousand | -292.14 Thousand | -144.42 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 41.26 Million | 402.55 Million | 115.76 Billion | 261.12 Million | - |
| Other Financing Activities | 41.26 Thousand | 402.55 Thousand | 1000.00 | 261.12 Thousand | 1000.00 |
| Accounts receivables | -165.83 Million | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -3.54 Million | 6.64 Million | 7.68 Million | -3.85 Million | -627.93 Thousand |
| Cash at beginning of period | 117.64 Billion | 164.89 Billion | 77.59 Billion | 95.99 Billion | 46.87 Million |
| Cash at end of period | 68.73 Billion | 115.63 Billion | 154.25 Billion | 71.21 Billion | 102.14 Million |
| Capital Expenditure | -791.38 Million | -2.47 Billion | -2.7 Billion | -1.08 Billion | -433.14 Thousand |
| Effect of forex changes on cash | -97.53 Million | -3.07 Billion | -682.37 Million | -533 Thousand | 6777.00 |
| Net cash flow / Change in cash | -48.9 Billion | -49.26 Billion | 76.65 Billion | -24.77 Billion | 55.27 Million |
| Free Cash Flow | -50.55 Billion | -44.88 Billion | -36.59 Billion | -29.99 Billion | -15.22 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.44 Billion | -11.81 Billion | -9.62 Billion | -52.74 Billion | -14.27 Billion | -16.92 Billion |
| Depreciation & Amortization | - | - | 3.2 Million | 3.2 Billion | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 5.89 Billion | - | - |
| Change in working capital | - | - | -3.54 Million | -3.54 Billion | - | - |
| Other non-cash items | 1.78 Billion | 155.02 Million | -4.13 Billion | -2.61 Billion | 1.15 Billion | 3.11 Billion |
| Investing Cash Flow | 474.58 Million | 503.95 Million | 621.12 Million | 2.08 Billion | 1.04 Billion | -127.05 Million |
| Investments in PPE | -53.72 Million | -19.44 Million | -6.1 Million | -791.38 Million | -17.2 Million | -713.46 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 925 Thousand | -19.42 Million | 15.89 Million | 39.73 Million | 23.58 Million | 579.67 Thousand |
| Financing Cash Flow | -324.57 Million | -324.07 Million | -272.08 Million | -1.13 Billion | -322.91 Million | -267.83 Million |
| Debt repayment | - | -324.07 Thousand | - | -1.17 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1773.00 | - | - | - |
| Common Stock Issuance | - | - | -1.77 Million | 41.26 Million | 1.02 Million | - |
| Other Financing Activities | -324.57 Million | - | -270.31 Thousand | 41.26 Thousand | -322.91 Thousand | -264.78 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -3.54 Million | -3.54 Million | - | - |
| Cash at beginning of period | 59.19 Billion | 71.79 Billion | 80.37 Billion | 117.64 Billion | 89.9 Billion | 102.82 Billion |
| Cash at end of period | 52.4 Billion | 59.19 Billion | 68.73 Billion | 68.73 Billion | 80.37 Billion | 89.9 Billion |
| Capital Expenditure | -53.72 Million | -19.44 Million | -6.1 Million | -791.38 Million | -17.2 Million | -713.46 Million |
| Effect of forex changes on cash | -464.6 Million | -1.03 Billion | 904.89 Million | -97.53 Million | 46.91 Million | -769.13 Million |
| Net cash flow / Change in cash | -6.79 Billion | -12.6 Billion | -11.64 Billion | -48.9 Billion | -9.52 Billion | -12.92 Billion |
| Free Cash Flow | -8.78 Billion | -11.77 Billion | -7.84 Billion | -50.55 Billion | -13.23 Billion | -14.6 Billion |
NIM
ELECTCAST
RBLBANK
MAITHANALL
5071
SABEVENTS